SPRC - SciSparc announces of $10 million in private placement offering

SciSparc Ltd (NASDAQ:SPRC)  -9.68%  has  a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system. The company  is focused into the institutional investor for aggregate gross proceeds of approximately $10 million and expenses  is payable   by the company. The Company will issue 3,546,100 units and  at a purchase price of $2.82 per unit . Each unit is consist of one ordinary share . The Company  is acting as the Exclusive Placement Agent in connection with the offering and is expected to close a offering on 1 June, 2022. Source: Press Release

For further details see:

SciSparc announces of $10 million in private placement offering